NCT00568763 Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT00568451 Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma Status TERMINATED Phase PHASE2
NCT00567970 Stereotactic Radiation Therapy in Treating Patients With Liver Metastases Status COMPLETED Phase PHASE1
NCT00566553 The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women Status COMPLETED Phase NA
NCT00566280 Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge Status COMPLETED Phase NA
NCT00566228 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Status COMPLETED Phase PHASE3
NCT00566085 New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer Status COMPLETED Phase NA
NCT00564889 Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Status COMPLETED Phase PHASE2
NCT00562328 Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00558896 CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis Status COMPLETED Phase PHASE2
NCT00498368 Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Status COMPLETED Phase PHASE4
NCT00486421 Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura Status COMPLETED Phase EARLY_PHASE1
NCT00484887 Characterization of Explanted Hernia Meshes From Human Subjects: A Multi-Center, Prospective Study Status TERMINATED Phase N/A
NCT00482495 Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00482378 Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain Status COMPLETED Phase PHASE1/PHASE2